Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Optimizing neuropathic pain pharmacotherapy: add on or switch over?

Nature Clinical Practice Neurology volume 4, pages 414–415 (2008)Cite this article

boxed-text Hanna M et al. (2008) Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain [doi:10.1016/j.ejpain.2007.12.010]

Oxycodone added on to gabapentin is safe and effective at reducing neuropathic pain; however, whether add-on oxycodone is any better than switching from gabapentin to oxycodone alone has yet to be determined

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dworkin RH et al. (2003) Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60: 1524–1534

    Article  Google Scholar 

  2. Finnerup NB et al. (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118: 289–305

    Article  CAS  Google Scholar 

  3. Gilron I and Max MB (2005) Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 5: 823–830

    Article  CAS  Google Scholar 

  4. Tarride JE et al. (2006) The economic burden of neuropathic pain in Canada. J Med Econ 9: 55–68

    Article  Google Scholar 

  5. Gilron I et al. (2005) Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352: 1324–1334

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Lisa Richards, Editorial Assistant, Nature Clinical Practice.

Author information

Author notes

  1. Department of Anesthesiology, Kingston General Hospital, 76 Stuart Street, Kingston, ON K7L 2V7, Canada gilroni@queensu.ca

Authors and Affiliations

  1. I Gilron is Associate Professor of Anesthesiology and Pharmacology and Director of Clinical Pain Research at Queen's University, Kingston, ON, Canada.,

    Ian Gilron

Authors
  1. Ian Gilron
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has acted as a consultant for Pfizer and has received grant/research support from Aventis Pharma, Novopharm, Pharmascience and Pfizer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilron, I. Optimizing neuropathic pain pharmacotherapy: add on or switch over?. Nat Rev Neurol 4, 414–415 (2008). https://doi.org/10.1038/ncpneuro0836

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0836

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing